Sort
30,917 grants matching “tumor microenvironment”
MOLECULAR MECHANISMS UNDERLYING ACAID INDUCTION
$380,644Sharmila Masli · Schepens Eye Research Institute · R01 · FY2007 · EY
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$380,627Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2021 · CA
Mechanism of LSD1 in breast cancer metastasis suppression
$380,549Zhe Li · Brigham And Women'S Hospital · R01 · FY2025 · CA
Mechanism of LSD1 in breast cancer metastasis suppression
$380,549Zhe Li · Brigham And Women'S Hospital · R01 · FY2021 · CA
Project 2: Racial/ethnic differences, impact on tumor microenvironment and mortality
$380,533Ulrike Peters · Fred Hutchinson Cancer Center · P20 · FY2022 · CA
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$380,517Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2020 · CA
Impact of extracellular glutathione catabolism on triple-negative breast cancer
$380,503Isaac Spencer Harris · University Of Rochester · R01 · FY2023 · CA
Endocrine disruption of myometrial stem cell activities
$380,489Jose M Teixeira · Michigan State University · R01 · FY2013 · OD
Mechanochemical Effects on Tumor Cell Signaling, Adhersion and Migration
$380,486Konstantinos Konstantopoulos · Johns Hopkins University · U54 · FY2011 · CA
Investigating serum exosomal annexin A2 in promoting aggressive TNBC in African American women
$380,476Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · R01 · FY2017 · CA
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$380,473David P Carbone · Ohio State University · R01 · FY2023 · CA
Biochemistry of MT1-MMP activation in malignancy
$380,472Alex Y Strongin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA
Biochemistry of MT1-MMP activation in malignancy
$380,472Alex Y Strongin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses
$380,460Elena Vinogradov · Ut Southwestern Medical Center · R01 · FY2024 · CA
Role of microbial-modulated bile acid receptor signaling in breast cancer
$380,449Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches
$380,402Keith Syson Chan · Cedars-Sinai Medical Center · R01 · FY2021 · CA
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$380,325Ann Richmond · Vanderbilt University · R01 · FY2023 · CA
Penn Small Animal Imaging Resource (Penn-SAIR)
$380,325Jerry D Glickson · University Of Pennsylvania · U24 · FY2007 · CA
Role of newly identified, thyroid-specific LincRNA in BRAFV600E thyroid carcinoma
$380,298Carmelo Nucera · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
$380,298Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Interleukin-35 and the tumor microenvironment
$380,292Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
$380,278Don X Nguyen · Yale University · R01 · FY2016 · CA
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
$380,278Don X Nguyen · Yale University · R01 · FY2017 · CA
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
$380,278Don X Nguyen · Yale University · R01 · FY2015 · CA
Targeting the Immunosuppressive Tumor Microenvironment for Colorectal Cancer Treatment
$380,262Qingding Wang · University Of Kentucky · R01 · FY2024 · CA